U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 468 records

Showing results for "vascular".

  1. Treatment of Non-metastatic Muscle-invasive Bladder Cancer | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/bladder-cancer-muscle-invasive/research-protocol
    December 01, 2020 - cytokeratin fragment$ or cyfra 21-1 or (cytokerat$ adj3 (tpa or tps)) or survivin or telomeras$ or vascular

  2. Interventions for Preventing Cognitive Decline, Mild Cognitive Impairment, and Alzheimer’s Disease | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/cognitive-decline/research-protocol
    December 01, 2020 - with components addressing nutrition, physical activity, cognitive training, social activity, and/or vascular

  3. Lower Limb Prosthesis | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/prosthesis/research-protocol
    January 01, 2019 - since last assessment Age Comorbidities that may affect use of LLP (e.g., congestive heart failure, vascular

  4. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - syndrome (Miller Fisher syndrome), cardiovascular events (myocardial infarction, cardiac disorders, major vascular … and subcutaneous tissue disorders • Social circumstances • Surgical and medical procedures • Vascular

  5. PULMONARY with "Discussions" in Exec Summary (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
    October 01, 2015 - proangiogenic growth factor receptors purportedly involved in the pathogenesis of IPF, including vascular … intracellular signaling by inhibiting the proliferative growth factor receptor kinase activity of vascular

  6. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fetal-surgery_disposition-comments.pdf
    July 05, 2011 - to confusion: itIS a specialized balloon, but only to the extend that itwas specially designed for vascular … Peer Reviewer #13 Results Change "the shared placenta" to "intertwin placental vascular anastomoses

  7. PULMONARY with "Discussions" in Exec Summary (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - proangiogenic growth factor receptors purportedly ES-6 involved in the pathogenesis of IPF, including vascular … intracellular signaling by inhibiting the proliferative growth factor receptor kinase activity of vascular … solution also contains a low concentration of potassium ions to reduce free-radical generation and avoid vascular

  8. Bladder-Cancer-Muscle-Invasive Research-Protocol (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/bladder-cancer-muscle-invasive_research-protocol.pdf
    July 21, 2014 - cytokeratin fragment$ or cyfra 21-1 or (cytokerat$ adj3 (tpa or tps)) or survivin or telomeras$ or vascular

  9. Assessing Applicability (ppt file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
    January 01, 2009 - surgeons with extensive experience and low complication rates and are not representative of average vascular

  10. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
    March 22, 2016 - with components addressing nutrition, physical activity, cognitive training, social activity, and/or vascular

  11. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
    March 01, 2009 - nitroglycerin use), other cardiovascular conditions (e.g., valvular disease, aneurysms, and peripheral vascular

  12. Er r or Rate Reduction Regarding Lower Limb Prosthesis (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prosthesis_research-protocol.pdf
    March 16, 2017 - assessment • Age • Comorbidities that may affect use of LLP (e.g., congestive heart failure, vascular

  13. CER 222: Evidence Summary: Achieving Health Equity in Preventive Services (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-222-evidence-summary-health-equity.pdf
    January 01, 2020 - 0 7 3 1 13c Lung cancer screening 0 0 0 0 1 Tobacco smoking cessation 0 3 1 2 0 Cardio- vascular

  14. The Role of Immunotherapy and the Management of Asthma: Systematic Review | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/asthma-immunotherapy/research-protocol
    April 01, 2021 - The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic

  15. Depression Treatment after Unsatisfactory Response to SSRIs when used as First-line Therapy | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/products/depression-treatment-ssri/research-protocol
    December 01, 2019 - patients having initially sustained a cerebrovascular accident, Dementias (including Alzheimer’s disease, Vascular

  16. Data Points 14: Use of Endocrine Therapy (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
    August 01, 2012 - Data Points • # 14 • Use of Endocrine Therapy 2 AI use is associated with increased cardio- vascular

  17. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/glaucoma_screening-apendices-11-5-10.pdf
    December 23, 2009 - OCULAR CEREBRAL VASCULAR MONITOR SE 11/28/1977 EYE-DEAS LLC EYESOPEN TONOMETER SE 9/23/2003 FALCK MEDICAL

  18. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-screening-apendices-11-5-10.pdf
    December 23, 2009 - OCULAR CEREBRAL VASCULAR MONITOR SE 11/28/1977 EYE-DEAS LLC EYESOPEN TONOMETER SE 9/23/2003 FALCK MEDICAL

  19. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - However, the long-term effects of this mode of insulin therapy on micro- and macro vascular complications … Poorly controlled prandial glucose levels worsen HbA1C in the longterm, predisposing to vascular complications … inflammation that occurs in DME and that corticosteroids exert a therapeutic effect by modulating vascular … followup.153 The fluocinolone acetonide implant will probably compete with ranibizumab (Lucentis®), a vascular

  20. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
    September 25, 2013 - Although the original concept for the report was to cover a wide range of uses of clopidogrel in vascular … the literature does not include many studies of clopidogrel use in cerebrovascular and peripheral vascular … It is well established that patients with vascular disease have higher levels of reactivity compared
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites